KAPA
What one share of Kairos Pharma holds
Pharmaceutical Preparations
Kairos Pharma’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.28 |
|---|---|
| Cash and investments | $0.12 |
| Book value | $0.20 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | — | −$0.17 | — | — | — | −$0.20 |
| 2024 | — | −$0.23 | — | — | — | $0.35 |
| 2025 | — | −$0.30 | — | — | — | $0.30 |
Common questions about Kairos Pharma
How much does one share of Kairos Pharma earn?
Over the last 12 months, Kairos Pharma lost $0.28 for each share.
Does Kairos Pharma pay a dividend?
Kairos Pharma didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Kairos Pharma’s book value per share?
Kairos Pharma’s book value is $0.20 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Kairos Pharma have?
Each share of Kairos Pharma has $0.12 of cash and investments, as of June 30, 2026.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.